119 related articles for article (PubMed ID: 25435270)
21. FDG-PET nodal staging does not correlate with histopathological nodal stage for oesophageal cancers.
Devadas M; Mittal A; Lin M; Cosman P; Ziazaris W; Wilson R; Das A; Merrett N
Int J Surg; 2015 Aug; 20():113-7. PubMed ID: 26118612
[TBL] [Abstract][Full Text] [Related]
22. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
[TBL] [Abstract][Full Text] [Related]
23. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
[TBL] [Abstract][Full Text] [Related]
24. Comparison of special interest computed tomography, endosonography and histopathological stage of oesophageal cancer.
Weaver SR; Blackshaw GR; Lewis WG; Edwards P; Roberts SA; Thomas GV; Allison MC
Clin Radiol; 2004 Jun; 59(6):499-504. PubMed ID: 15145719
[TBL] [Abstract][Full Text] [Related]
25. Impact of Endoscopic Ultrasonography on
Hulshoff JB; Mul VEM; de Boer HEM; Noordzij W; Korteweg T; van Dullemen HM; Nagengast WB; Oppedijk V; Pierie JPEN; Plukker JTM
Ann Surg Oncol; 2017 Jul; 24(7):1828-1834. PubMed ID: 28303427
[TBL] [Abstract][Full Text] [Related]
26. The role of endoscopic ultrasound (EUS) in planning radiotherapy target volumes for oesophageal cancer.
Thomas E; Crellin A; Harris K; Swift S; Montefiore DS
Radiother Oncol; 2004 Nov; 73(2):149-51. PubMed ID: 15542161
[TBL] [Abstract][Full Text] [Related]
27. [Role of [18]-FDG PET/CT in the initial staging of head and neck cancers].
Fakhry N; Barberet M; Lussato D; Mundler O; Giovanni A; Zanaret M
Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):3-9. PubMed ID: 17633658
[TBL] [Abstract][Full Text] [Related]
28. Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival.
Ganeshan B; Skogen K; Pressney I; Coutroubis D; Miles K
Clin Radiol; 2012 Feb; 67(2):157-64. PubMed ID: 21943720
[TBL] [Abstract][Full Text] [Related]
29. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
[TBL] [Abstract][Full Text] [Related]
30. Preoperative evaluation of oesophageal adenocarcinoma.
Khanna LG; Gress FG
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):179-91. PubMed ID: 25743465
[TBL] [Abstract][Full Text] [Related]
31. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.
Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR
Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147
[TBL] [Abstract][Full Text] [Related]
32. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF
Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570
[TBL] [Abstract][Full Text] [Related]
33. PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma.
Blom RL; Steenbakkers IR; Lammering G; Vliegen RF; Belgers EJ; de Jonge C; Schreurs WM; Nap M; Sosef MN
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1500-6. PubMed ID: 23764889
[TBL] [Abstract][Full Text] [Related]
34. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
35. Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy.
Findlay JM; Bradley KM; Maile EJ; Braden B; Maw J; Phillips-Hughes J; Gillies RS; Maynard ND; Middleton MR
Br J Surg; 2015 Nov; 102(12):1488-99. PubMed ID: 26458070
[TBL] [Abstract][Full Text] [Related]
36. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging.
Erasmus JJ; Munden RF; Truong MT; Ho JJ; Hofstetter WL; Macapinlac HA; Correa AM; Wu TT; Bruzzi JF; Marom EM; Sabloff BS; Ajani JA; Komaki R; Liao Z; Lee JH; Fukami N; Bresalier R; Swisher SG
J Thorac Oncol; 2006 Jun; 1(5):478-86. PubMed ID: 17409902
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic ultrasound in esophageal carcinoma: comparison with multislice computed tomography and importance in the clinical decision making process.
Moorjani N; Junemann-Ramirez M; Judd O; Fox B; Rahamim JS
Minerva Chir; 2007 Aug; 62(4):217-23. PubMed ID: 17641581
[TBL] [Abstract][Full Text] [Related]
38. The additional value of PET/CT over PET in FDG imaging of oesophageal cancer.
Bar-Shalom R; Guralnik L; Tsalic M; Leiderman M; Frenkel A; Gaitini D; Ben-Nun A; Keidar Z; Israel O
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):918-24. PubMed ID: 15838691
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic value of the metabolically active tumour volume].
Paumier A; Marquis A; Trémolières P; Lacombe M; Capitain O; Septans AL; Peyraga G; Gustin P; Vénara A; Ménager É; Visvikis D; Couturier O; Rio E; Hatt M
Cancer Radiother; 2016 Feb; 20(1):24-9. PubMed ID: 26762703
[TBL] [Abstract][Full Text] [Related]
40. Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer.
Roedl JB; Sahani DV; Colen RR; Fischman AJ; Mueller PR; Blake MA
Eur Radiol; 2008 Dec; 18(12):2833-40. PubMed ID: 18651155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
